Hui Li

Hui Li serves as President and CEO at Adcentrx Therapeutics. Adcentrx Therapeutics operates in the research sector with approximately 35.0 employees. The company is headquartered in San Diego, California. To date, Adcentrx Therapeutics has raised 50000000.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,742 executive contacts are available in California.
• • Our database includes 201,465 c suite-level executives.

Outlook Microsoft Office 365 Google Cloud Hosting Google Tag Manager Mobile Friendly Google Maps Nginx WordPress.org Micro Render Remote Basis AI

biotechnology research protein conjugate adcs antibody-drug conjugates cancer therapeutics targeted therapy biologics small molecule payloads bystander effect stable conjugation i-conjugation technology clinical-stage biotechnology drug development oncology cancer treatment therapeutic window payload delivery tumor penetration gmp production process development novel drug candidates fda-approved therapies broad therapeutic applications clinical trials drug discovery biotechnology innovation antibody targeting payload potency linker technologies reproducibility cost-efficiency biopharmaceuticals cancer immunotherapy site-specific adc products preclinical studies drug manufacturing competitive advantages therapeutic strategies pharmaceutical research clinical operations clinical development oncology research biologics engineering cancer vaccines therapeutic antibody engineering indication-specific approaches validation studies hospital & health care health care health wellness & fitness

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Hui Li in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Adcentrx Therapeutics.

Hui Li's Position in the MessageCEO Database

• •Hui Li is 1 of 1 verified executive contact we track at Adcentrx Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12,900 verified executive contacts in California are in the database.
• •36 verified contacts work at research companies in the 35.0 employee range (same size as Adcentrx Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Hui Li directly?

Hui Li's verified email address is available to MessageCEO Pro subscribers. They currently serve as President and CEO at Adcentrx Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Hui Li work for?

Hui Li is President and CEO at Adcentrx Therapeutics, a company in the research sector with 35.0 employees. The company is based in San Diego, California.

Can I pitch or sell to Hui Li?

As President and CEO at Adcentrx Therapeutics, Hui Li is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Hui Li directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Hui Li in?

Hui Li works in the research industry as President and CEO at Adcentrx Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Hui Li's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Hui Li's profile is kept up-to-date with the latest available information.

Last updated: October 9, 2026